Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 68
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01610479 | A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors | ||
| NCT00077142 | TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) | ||
| NCT00569790 | Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal Cancer | ||
| NCT02322593 | Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer | ||
| NCT00202969 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | ||
| NCT03175029 | Exploratory Study of TAC-302 in Detrusor Underactivity Patients With Overactive Bladder. | ||
| NCT02564367 | Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction | ||
| NCT04825431 | Mass Balance Study of [14C] TAS-205 in Healthy Volunteers | ||
| NCT01955837 | Study of Trifluridine/Tipiracil (TAS-102) in Patients With Metastatic Colorectal Cancer in Asia | ||
| NCT01534546 | Phase III Study to Compare Perioperative Chemotherapy of Oxaliplatin Combined With S-1(SOX) Versus SOX or Oxaliplatin With Capecitabine (XELOX) as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma With D2 Dissection | ||
| NCT01824459 | S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients | ||
| NCT00150670 | Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer | ||
| NCT00229424 | Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - | ||
| NCT00569335 | Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal Cancer | ||
| NCT00166543 | Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer | ||
| NCT00784290 | Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma | ||
| NCT00152243 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) | ||
| NCT02943733 | Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs | ||
| NCT02090153 | Study of S-1 Plus LV for Advanced Gastric Cancer | ||
| NCT05245968 | A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101) | ||
| NCT00602745 | S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen | ||
| NCT01465464 | Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma | ||
| NCT01811277 | SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer | ||
| NCT04999761 | AB122 Platform Study | ||
| NCT01679340 | A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery | ||
| NCT05773092 | A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC | ||
| NCT05621447 | A Mass Balance Study of [14C] TAS-303 in Healthy Adult Male Subjects | ||
| NCT00359567 | Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy | ||
| NCT00429858 | Gemcitabine and S-1 for Locally Advanced Unresectable or Metastatic Pancreatic Cancer | ||
| NCT02752048 | A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy | ||
| NCT04587908 | A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy（REACH-DMD） | ||
| NCT03605251 | Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis. | ||
| NCT00152230 | A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC) | ||
| NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | ||
| NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | ||
| NCT02261532 | A Phase I Study of TAS-102 in Solid Tumors | ||
| NCT05691660 | A Study of TAS3731 in Healthy Adults | ||
| NCT00824161 | Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer | ||
| NCT02602327 | Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases | ||
| NCT04074343 | TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma | ||
| NCT05568095 | A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body | ||
| NCT02562807 | A Study of TAS-303 in Female Patients With Stress Urinary Incontinence | ||
| NCT04512053 | A Phase 2 Study of TAS-303 in Female Patients With Stress Urinary Incontinence | ||
| NCT00661167 | Phase II Study of ABI-007 for Gastric Cancer | ||
| NCT05335499 | A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous Urticaria | ||
| NCT00569699 | Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC) | ||
| NCT00770874 | Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer | ||
| NCT04920032 | Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas | ||
| NCT02906683 | Exploratory Trial of TAS-303 in Female Patients With Stress Urinary Incontinence | ||
| NCT02128243 | Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer |
